^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SCRI-CARB7H3(s)

    i
    Other names: SCRI-CARB7H3(s) , second generation 4-1BBζ B7H3-EGFRt-DHFR , Autologous CD4+ and CD8+ T-cells genetically modified to express an B7H3-specific CAR, B7H3-specific CAR
    Company:
    Cellevolve Bio, Seattle Children's Hospital, Seattle Children’s Therapeutics
    Drug class:
    B7-H3-targeted CAR-T immunotherapy
    Related drugs: